3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
8
Breast Neoplasms
7
Prostatic Neoplasms
6
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Urinary Bladder Neoplasms
5
Glioma
5
Astrocytoma
5
Oropharyngeal Neoplasms
4
Esophageal Neoplasms
4
Carcinoma
4
Burkitt Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Rectal Neoplasms
3
Neoplasm Metastasis
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Liposarcoma
2
Laryngeal Neoplasms
2
Hodgkin Disease
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Cyclophosphamide
2
tazemetostat
1
talazoparib
1
selinexor
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
atezolizumab
1
Vincristine
1
Vinblastine
1
Vemurafenib
1
Topotecan
1
Tiragolumab
1
Temozolomide
1
Pharmacogenomic Variants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Radiation
×
30 days
×
Clear all
No trials found.